LncRNA NEAT1 |
MPTP mouse model and MPP+‐induced SH‐SY5Y |
Regulating neuronal injury by targeting miR‐124; promoting autophagy through stabilizing PINK1 protein |
78, 100
|
LncRNA HAGLROS |
MPTP mouse model and MPP+‐induced SH‐SY5Y |
Regulating apoptosis and autophagy via regulating miR‐100/ATG10 axis and PI3K/Akt/mTOR pathway activation |
79
|
LncRNA HOTAIR |
Midbrain tissue of MPTP induced PD mice and SH‐SY5Y cells exposed to MPP+
|
Promoting PD by upregulating LRRK2 expression; targeting miR‐126‐5p to promote PD through RAB3IP |
83, 112
|
LncRNA SNHG1 |
SH‐SY5Y cells |
Promoting α‐synuclein aggregation and toxicity by targeting miR‐15b‐5p to activate SIAH1 |
84
|
LncRNA MALAT1 |
MPTP mouse model and MPP+‐induced SH‐SY5Y; MN9D cells |
α‐synuclein protein expression; regulating cell apoptosis by directly targeting LRRK2 through lncRNA MALAT1/miR‐205‐5p axis |
85, 98
|
LncRNA UCA1 |
Substantia nigra striatum of 6‐OHDA PD model; MPTP mouse model and MPP+‐induced SH‐SY5Y |
The damage of dopaminergic neurons, oxidative stress and inflammation by the PI3K/Akt signaling pathway; promoting PD development by upregulating SNCA |
94, 99
|
LncRNA‐p21 |
SH‐SY5Y cells |
Regulating MPP+‐induced neuronal injury by targeting miR‐625 and derepressing TRPM2 |
95
|
Nrf2‐related lncRNAs |
Substantia nigra of paraquat and MPTP induced mouse model |
Oxidative stress |
96
|
LncRNA AS Uchl1 |
Dopaminergic cells' differentiation in vitro and in neurochemical models of PD |
Expression is under the regulation of Nurr1 |
110
|
PINK1‐AS, UCHL1‐AS, BCYRN1, SOX2‐OT, ANRIL and HAR1A |
PD in the Hungarian population |
Interfering with the binding affinity of transcription factor HNF4A, potentially resulting in abnormal expression of target genes, such as BCYRN1 |
111
|
Sox2OT |
Anti‐NGF AD11 transgenic mouse |
Regulating cotranscribed Sox2 gene expression to down neurogenesis |
113
|